Download Free Sample Report

Head and Neck Cancer Diagnostics Market, Global Outlook and Forecast 2023-2032

Head and Neck Cancer Diagnostics Market, Global Outlook and Forecast 2023-2032

  • Published on : 18 September 2023
  • Pages :62
  • Report Code:SMR-7814734

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Head and neck cancer begins in squamous cells that line the mucosal surfaces of the head and neck such as, inside the mouth, the nose, and the throat. The head and neck cancers include specific areas of the body such as oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary glands. Alcohol and tobacco are the two most common risk factors for head and neck cancers. Other risk factors for head and neck cancers include consumption of preserved or salted foods, occupational exposure to wood dust, Epstein-Barr virus infection, and poor oral hygiene.
This report aims to provide a comprehensive presentation of the global market for Head and Neck Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Head and Neck Cancer Diagnostics. This report contains market size and forecasts of Head and Neck Cancer Diagnostics in global, including the following market information:
Global Head and Neck Cancer Diagnostics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Head and Neck Cancer Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The market for head and neck cancer diagnostics is expected to increase year on year with an increasing incidence of the disease. Though this form of cancer is not prevalent in all its forms in the US, it has increased presence and incidence in countries of Asia, Africa and to some extent Europe, making its screening and early detection of high importance to affect proper treatment and care. Proper detection at an early stage can lead to proper treatment and long healthier life. Rise in the aging population that increased the prevalence of chronic diseases, especially head and neck related cancers, increasing awareness towards cancer, and rise in the healthcare expenditure of people and government. However, Low Adoption Rate of Digital Technology Based Systems, Conventional CT and MRI Scanners, Excise Duty Imposed on Sale of Medical Devices in Mature Markets
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Head and Neck Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Head and Neck Cancer Diagnostics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Head and Neck Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
Diagnostic Imaging
Endoscopy Screening
Bioscopy Screening
Blood Tests
Dental Diagnostic
Others
Global Head and Neck Cancer Diagnostics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Head and Neck Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Global Head and Neck Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Head and Neck Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Head and Neck Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Head and Neck Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Philips Healthcare
Siemens Healthcare
Varian Medical Systems
Outline of Major Chapters:
Chapter 1: Introduces the definition of Head and Neck Cancer Diagnostics, market overview.
Chapter 2: Global Head and Neck Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Head and Neck Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Head and Neck Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.